NASDAQ
4.50USD
-46.54 (-91.18%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
203.2M
P/E
—
EPS
—
Beta
1.32
52W range
4.01-54.97
Day range
4.01–5.00
Open
4.86
Prev close
51.04
Volume
38.1M
Avg volume
479.1K
Dividend
0.00
IPO
2025-02-07
https://www.benzinga.com/trading-ideas/movers/26/08/61086327/sionna-therapeutics-discontinues-cystic-fibrosis-drug-following-unfavorable-data-data-stock-tanks · 8/10/2026-1.00
https://www.defenseworld.net/2026/04/19/sionna-therapeutics-nasdaqsion-director-sells-10287918-04-in-stock.html · 4/19/2026+0.40
https://www.fool.com/coverage/filings/2026/01/03/a-sionna-therapeutics-sion-insider-sold-33-000-shares-for-usd1-5-million/ · 1/3/2026+0.20
Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis. This is achieved by developing innovative medicines designed to restore the normal function of the cystic fibrosis transmembrane conductance regulator.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
